Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva
- PMID: 38185793
- PMCID: PMC10925518
- DOI: 10.1111/os.13956
Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva
Abstract
Background: Fibrodysplasia ossificans progressiva (FOP) is an extremely rare disease characterized by malformation of the bilateral great toes and progressive heterotopic ossification. The clinical features of FOP occur due to dysfunction of the bone morphogenetic protein (BMP) signaling pathway induced by the mutant activin A type I receptor/activin-like kinase-2 (ACVR1/ALK2) which contributes to the clinical features in FOP. Dysregulation of the BMP signaling pathway causes the development of osteochondroma. Poor awareness of the association between FOP and osteochondromas always results in misdiagnosis and unnecessary invasive operation.
Case presentation: In this study, we present a case of classical FOP involving osteochondroma. An 18-year-old male adolescent, born with deformity of bilateral big toes, complained multiple masses on his back for 1 year. The mass initially emerged with a tough texture and did not cause pain. It was misdiagnosed as an osteochondroma. After two surgeries, the masses became hard and spread around the entire back region. Meanwhile, extensive heterotopic ossification was observed around the back, neck, hip, knee, ribs, and mandible during follow-up. Osteochondromas were observed around the bilateral knees. No abnormalities were observed in the laboratory blood test results. Whole exome sequencing revealed missense mutation of ACVR1/ALK2 (c.617G > A; p.R206H) in the patient and confirmed the diagnosis of FOP.
Conclusion: In summary, classical FOP always behaves as a bilateral deformity of the big toes, as well as progressive ectopic ossification and osteochondromas in the distal femur and proximal tibia. An understanding of the association between osteochondromas and FOP aids in diagnosis and avoids unnecessary invasive management in patients.
Keywords: ACVR1/ALK2; Association; Bone Morphogenetic Protein; Fibrodysplasia Ossificans Progressiva; Osteochondromas.
© 2024 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
All named authors have no conflicts of interest to disclose in relation to this article.
Figures




Similar articles
-
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.Stem Cell Res Ther. 2016 Aug 17;7(1):115. doi: 10.1186/s13287-016-0372-6. Stem Cell Res Ther. 2016. PMID: 27530160 Free PMC article.
-
Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva.J Bone Joint Surg Am. 2008 Feb;90(2):366-74. doi: 10.2106/JBJS.G.00774. J Bone Joint Surg Am. 2008. PMID: 18245597 Free PMC article.
-
BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).Dev Dyn. 2022 Jan;251(1):164-177. doi: 10.1002/dvdy.387. Epub 2021 Jun 26. Dev Dyn. 2022. PMID: 34133058 Free PMC article. Review.
-
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.Hum Mutat. 2009 Mar;30(3):379-90. doi: 10.1002/humu.20868. Hum Mutat. 2009. PMID: 19085907 Free PMC article.
-
Fibrodysplasia ossificans progressiva: clinical and genetic aspects.Orphanet J Rare Dis. 2011 Dec 1;6:80. doi: 10.1186/1750-1172-6-80. Orphanet J Rare Dis. 2011. PMID: 22133093 Free PMC article. Review.
References
-
- Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age‐ and joint‐specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1994;301:243–248. - PubMed
-
- Akesson LS, Savarirayan R. Fibrodysplasia Ossificans Progressiva [M]//Adam M P, Ardinger H H, Pagon R A, et al. GeneReviews (®). Seattle (WA): University of Washington, Seattle Copyright © 1993–2021, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources